Authority: National Company Law Appellate Tribunal Principal Bench, New Delhi
Order Date: September 25, 2026
Case Overview
The National Company Law Appellate Tribunal (NCLAT) Principal Bench in New Delhi issued a procedural order in Company Appeal (AT) (Insolvency) No. 1781 of 2026. The appeal involves Abhay Sapre, who is identified as the suspended director of FTF Pharma Private Limited, as the appellant. The respondents are Immacule Lifesciences Pvt. Ltd. & Anr. The order was issued in hybrid mode with legal representation from both sides: Senior Advocate Mr. K. Datta with a team of advocates representing the appellant, and advocates including Senior Advocate Mr. Gaurav Mitra representing respondent No. 1 (Immacule Lifesciences), and Mr. Anand Varma with Ms. Apoorva Pandey representing respondent No. 3. The bench consisted of Justice Mohammad Faiz Alam Khan (Member Judicial) and Indevar Pandey (Member Technical).
Final Outcome
The tribunal noted "No time left" and accordingly rescheduled the hearing of this appeal to September 28, 2026. The case is to be listed under the same caption as the first case on the board for that day. This is purely a procedural order for rescheduling without any substantive decision on the merits of the case.
Topics: NCLAT Proceeding, Corporate Insolvency, Director Suspension